A Chinese oral drug at a fifth of that price undermines the entire margin structure on which the whole pipeline is builtand affects every investment case." Shah says, Revenue per patient drops 60 to 80 percent, and return on investment models built today at Rs2,000-plus collapse." He adds, however, that Rs500 to Rs800 pricing would require either a heavy market-capture subsidy strategy or a lower-efficacy molecule
Heterogeneity statistics for overall and sex-specific analyses on genetically predicted l-carnitine and cardiovascular disease and its risk factors
When food sits in the stomach for an extended period, it can release gases containing sulfur, leading to the distinct sulfur belching some people experience on medications like semaglutide. Mild or occasional burping after starting a GLP-1 medication is typically normal, especially as your body adjusts to the treatment
The bSlim peptide weight loss program provided by biostation can span anywhere between two to three months
When the burden of IP Protection is lifted via the natural expiration of the patent term, the market shifts from a monopoly to a competitive environment where the patient is the ultimate beneficiary